Latest Breaking News On - Gen probe - Page 4 : comparemela.com
Colorectal Cancer Molecular Diagnostics Market Future Challenges, Industry Share, Segmentation & Ins
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Secondary Research, Primary Research, Company Share Analysis, Model ( including Macro-monetary pointers, Demographic information, and Industry pointers: Expenditure, foundation, area development, and offices ), Research Limitations and Revenue Based Modeling. Organization share examination is utilized to determine the size of the worldwide market. Just as an investigation of incomes of organizations for the last three to five years likewise gives the base to determine the market size and Shares (2021-2027 ) and its development rate. also, representing the Oncology based Molecular Diagnostics Market Factor Analysis-
Porter’s Five Forces, Supply/Value Chain, PESTEL analysis, CAGR value, product offerings, company landscape analysis, Market Entropy, CAPEX cycle, COGS Analysis, EBITDA analysis, Patent/Trademark Analysis, and Post COVID Impact Analysis. Key Leading Players having extreme Growth Rate in last Few decades included
Oncology Molecular Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030
The Business Research Company’s Oncology Molecular Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030
LONDON, GREATER LONDON, UK, April 22, 2021 /EINPresswire.com/ Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports
The rise in the number of cancer cases across the globe is likely to contribute to the growth of the oncology molecular diagnostics market. According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the oncology molecular diag
Share this article
Share this article
ResearchAndMarkets.com s offering.
Major players in the oncology molecular diagnostics market are Abbott Diagnostics, Becton Dickinson, Cepheid, Danaher Corporation, Beckman Coulter, Leica Biosystems, Gen Probe (Hologic), Qiagen N.V., Roche Diagnostics, and Siemens Healthcare.
The global oncology molecular diagnostics market is expected to decline from $5.58 billion in 2019 to $5.25 billion in 2020 at a compound annual growth rate (CAGR) of -5.81%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $7.41 billion in 2023 at a CAGR of 12.13%.
LIVE Chips News | One News Page
onenewspage.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onenewspage.com Daily Mail and Mail on Sunday newspapers.
vimarsana © 2020. All Rights Reserved.